Henrik Rasmussen
Fondateur chez Renibus Therapeutics, Inc.
Profil
Henrik Sandvad Rasmussen a fondé Rasmussen Biotech & Pharma Consulting LLC. Actuellement, le Dr Rasmussen est directeur médical d'Allakos, Inc. Le Dr Rasmussen siège également au conseil d'administration de Renibus Therapeutics, Inc. et de Neoprogen, Inc. Dans le passé, le Dr Rasmussen a été président et directeur général de Rasmussen Biotech & Pharma Consulting LLC, directeur médical de Nabi Pharmaceuticals, directeur d'étude mondial de Pfizer Central Research, premier vice-président de la recherche clinique et des affaires réglementaires de Vernalis Ltd, directeur médical de GenVec Inc, directeur médical d'Alba Therapeutics Corp, directeur médical et scientifique de ZS Pharma Inc, vice-président, responsable des affaires médicales et réglementaires de Novo-Nordisk Biochem Inc et directeur médical d'Altimmune Inc. Henrik Sandvad Rasmussen a obtenu un doctorat de l'université de Copenhague.
Postes actifs de Henrik Rasmussen
| Sociétés | Poste | Début |
|---|---|---|
Neoprogen, Inc.
 Neoprogen, Inc. BiotechnologyHealth Technology Neoprogen, Inc. engages in the development of cell-based therapy for people who experience a heart attack. The company was founded by Sunjay Kaushal, Rachana Mishra and Sudhish Sharma and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | - |
Renibus Therapeutics, Inc.
 Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Fondateur | 01/01/2015 |
Anciens postes connus de Henrik Rasmussen
| Sociétés | Poste | Fin |
|---|---|---|
| ALLAKOS INC. | Directeur Technique/Scientifique/R&D | 11/06/2021 |
| ZS PHARMA INC | Directeur Technique/Scientifique/R&D | 01/06/2016 |
| Rasmussen Biotech & Pharma Consulting LLC | Directeur Général | 01/01/2012 |
| Novo-Nordisk Biochem, Inc. | Directeur Technique/Scientifique/R&D | 01/07/2009 |
| Nabi Pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/02/2007 |
Formation de Henrik Rasmussen
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALLAKOS INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Altimmune, Inc. /Old/
 Altimmune, Inc. /Old/ Medical/Nursing ServicesHealth Services Altimmune, Inc. develops vaccines and other biological products. The firm offers products for use in companion and commercial livestock, including cats, dogs, horses, swine, poultry and aquaculture. The company was founded by G. Michael Alder and De-chu Tang in 1997 and is headquartered in Gaithersburg, MD. | Health Services |
| Rasmussen Biotech & Pharma Consulting LLC | |
| Novo-Nordisk Biochem, Inc. | |
| Nabi Pharmaceuticals | |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Health Technology |
Neoprogen, Inc.
Neoprogen, Inc. BiotechnologyHealth Technology Neoprogen, Inc. engages in the development of cell-based therapy for people who experience a heart attack. The company was founded by Sunjay Kaushal, Rachana Mishra and Sudhish Sharma and is headquartered in Baltimore, MD. | Health Technology |
Renibus Therapeutics, Inc.
Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Health Technology |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
